Trailblazing the path to drugging transcription factors by leveraging our discovery engine which integrates genetic, biochemical, and chemical insights to reveal druggable pockets in key conformational regions of TFs in order to identify small molecule ligands capable of modulating TFs of high therapeutic potential.
